Suppr超能文献

阴道脱垂手术中的合成移植物增强术:长期客观和主观结果

Synthetic Graft Augmentation in Vaginal Prolapse Surgery: Long-Term Objective and Subjective Outcomes.

作者信息

Meyer Isuzu, McGwin Gerald, Swain Thomas A, Alvarez Mitchell D, Ellington David R, Richter Holly E

机构信息

Division of Urogynecology and Pelvic Reconstructive Surgery, University of Alabama at Birmingham, Birmingham, AL.

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL.

出版信息

J Minim Invasive Gynecol. 2016 May-Jun;23(4):614-21. doi: 10.1016/j.jmig.2016.02.014. Epub 2016 Feb 23.

Abstract

OBJECTIVE

To report long-term objectives and subjective outcomes in women who underwent prolapse surgery with a synthetic graft augmentation.

DESIGN

Retrospective analysis (Canadian Task Force classification II-3).

SETTING

University hospital in the southeastern United States.

PATIENTS

Women with symptomatic pelvic organ prolapse who underwent transvaginal graft augmentation using the Prolift mesh system between July 2006 and December 2008 for a minimum 5-year follow-up.

INTERVENTIONS

Subjects completed the Pelvic Floor Distress Inventory (PFDI-20), the Pelvic Floor Impact Questionnaire (PFIQ-7), the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ), and the Patient Satisfaction Questionnaire. Subjects also underwent postoperative physical examination with Pelvic Organ Prolapse Quantification (POP-Q) and vaginal pain/stricture assessment. Long-term postoperative findings were compared with preoperative baseline data.

MEASUREMENTS AND MAIN RESULTS

Of 208 eligible subjects, 70 completed the questionnaires only, and 48 of these 70 provided both postoperative examination and questionnaire data. The mean duration of follow-up was 7.0 ± 0.7 years (range, 5.8-8.1 years). POP-Q measurements of Ba (point B anterior), Bp (B posterior), C (cervix), GH (genital hiatus), PB (perineal body), and overall pelvic organ prolapse stage were significantly improved (all p < .001 except for PB, p = .006). PFIQ-7 (total, Urinary Impact Questionnaire, and Pelvic Organ Prolapse Impact Questionnaire) and PFDI-20 (total, Urinary Distress Inventory, and Pelvic Organ Prolapse Distress Inventory) scores significantly improved (all p < .001). No differences were noted in the colorectal-anal subscales (Colorectal-Anal Impact Questionnaire and Colorectal-Anal Distress Inventory) and PISQ scores at >5-year follow-up (all p > .05). Satisfaction rates were 15.7% for not at all, 35.7% for somewhat, and 48.6% for completely satisfied. Complications included graft exposure (n = 3; 6%) and dyspareunia (n = 25; 36%).

CONCLUSION

Women undergoing transvaginal prolapse surgery using a synthetic graft continue to have positive objective and subjective outcomes, leading to significantly improved quality of life at a minimum 5-year follow-up.

摘要

目的

报告接受合成补片增强盆底脱垂手术的女性的长期目标和主观结果。

设计

回顾性分析(加拿大工作组分类II-3)。

地点

美国东南部的大学医院。

患者

2006年7月至2008年12月期间接受经阴道使用Prolift补片系统进行补片增强手术治疗有症状盆腔器官脱垂的女性,进行至少5年的随访。

干预措施

受试者完成盆底功能障碍量表(PFDI-20)、盆底功能影响问卷(PFIQ-7)、盆腔器官脱垂/尿失禁性功能问卷(PISQ)和患者满意度问卷。受试者还接受术后体格检查,包括盆腔器官脱垂定量评估(POP-Q)和阴道疼痛/狭窄评估。将术后长期结果与术前基线数据进行比较。

测量指标及主要结果

208名符合条件的受试者中,70名仅完成问卷,这70名中的48名同时提供了术后检查和问卷数据。平均随访时间为7.0±0.7年(范围5.8 - 8.1年)。Ba(前位B点)、Bp(后位B点)、C(宫颈)、GH(生殖裂孔)、PB(会阴体)的POP-Q测量值以及总体盆腔器官脱垂分期均有显著改善(除PB外,所有p <.001,PB的p = 0.006)。PFIQ-7(总分、尿失禁影响问卷和盆腔器官脱垂影响问卷)和PFDI-20(总分、尿失禁量表和盆腔器官脱垂量表)得分显著改善(所有p <.001)。在5年以上随访时,结直肠-肛门分量表(结直肠-肛门影响问卷和结直肠-肛门量表)和PISQ得分无差异(所有p >.05)。满意度方面,完全不满意为15.7%,有点满意为35.7%,完全满意为48.6%。并发症包括补片暴露(n = 3;6%)和性交困难(n = 25;36%)。

结论

接受经阴道使用合成补片的盆底脱垂手术的女性在至少5年的随访中,客观和主观结果持续呈阳性,生活质量显著改善。

相似文献

1
Synthetic Graft Augmentation in Vaginal Prolapse Surgery: Long-Term Objective and Subjective Outcomes.
J Minim Invasive Gynecol. 2016 May-Jun;23(4):614-21. doi: 10.1016/j.jmig.2016.02.014. Epub 2016 Feb 23.
2
Anterior-apical single-incision mesh surgery (SIMS): surgical and functional outcomes at 1 year.
J Minim Invasive Gynecol. 2015 Jan;22(1):50-6. doi: 10.1016/j.jmig.2014.07.002. Epub 2014 Jul 10.
5
Long-term follow-up of patients treated by transvaginal mesh repair for anterior prolapse.
Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:124-129. doi: 10.1016/j.ejogrb.2018.09.022. Epub 2018 Sep 17.
6
Two years follow up of 270 patients treated by transvaginal mesh for anterior and/or apical prolapse.
Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:16-22. doi: 10.1016/j.ejogrb.2016.10.015. Epub 2016 Nov 11.
9
One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series.
J Minim Invasive Gynecol. 2010 Jul-Aug;17(4):473-9. doi: 10.1016/j.jmig.2010.03.003. Epub 2010 May 23.
10
[Long-term effectiveness of transvaginal high uterosacral ligament suspension].
Zhonghua Fu Chan Ke Za Zhi. 2017 Jun 25;52(6):363-368. doi: 10.3760/cma.j.issn.0529-567X.2017.06.002.

引用本文的文献

1
Quality-of-life improvements in patients after various surgical treatments for pelvic organ prolapse.
Arch Gynecol Obstet. 2024 Mar;309(3):813-820. doi: 10.1007/s00404-023-07140-3. Epub 2023 Jul 19.
4
Current surgical management of pelvic organ prolapse: Strategies for the improvement of surgical outcomes.
Investig Clin Urol. 2019 Nov;60(6):413-424. doi: 10.4111/icu.2019.60.6.413. Epub 2019 Oct 29.
5
Surgical Updates in the Treatment of Pelvic Organ Prolapse.
Rambam Maimonides Med J. 2017 Apr 28;8(2):e0017. doi: 10.5041/RMMJ.10294.
6
Response to Letter to the Editor: Author's Reply.
J Minim Invasive Gynecol. 2017 Jan 1;24(1):179-180. doi: 10.1016/j.jmig.2016.08.812. Epub 2016 Aug 17.

本文引用的文献

1
Risk factors for vaginal mesh exposure after mesh-augmented anterior repair: a retrospective cohort study.
Female Pelvic Med Reconstr Surg. 2014 Nov-Dec;20(6):305-9. doi: 10.1097/SPV.0000000000000095.
3
Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery.
Obstet Gynecol. 2014 Jun;123(6):1201-1206. doi: 10.1097/AOG.0000000000000286.
4
Mesh exposure and associated risk factors in women undergoing transvaginal prolapse repair with mesh.
Obstet Gynecol Int. 2013;2013:926313. doi: 10.1155/2013/926313. Epub 2013 Sep 8.
5
Surgical management of pelvic organ prolapse in women.
Cochrane Database Syst Rev. 2013 Apr 30(4):CD004014. doi: 10.1002/14651858.CD004014.pub5.
6
Transvaginal Prolift(®) mesh surgery due to advanced pelvic organ prolapse does not impair female sexual function: a prospective study.
Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):295-8. doi: 10.1016/j.ejogrb.2012.07.011. Epub 2012 Aug 9.
7
Pelvic organ prolapse transvaginal repair by the Prolift system: evaluation of efficacy and complications after a 4.5 years follow up.
Int J Urol. 2012 Nov;19(11):1010-6. doi: 10.1111/j.1442-2042.2012.03090.x. Epub 2012 Jul 3.
8
Prospective clinical assessment of the transvaginal mesh technique for treatment of pelvic organ prolapse-5-year results.
Female Pelvic Med Reconstr Surg. 2011 May;17(3):139-43. doi: 10.1097/SPV.0b013e3182175da6.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验